Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop
Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop
01/30/25, 12:37 PM
Location
parisIndustry
biotechnology
health care
manufacturing
Type
partnership
Today, Curium announced the expansion of its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to make Iodine-131 diagnostic capsules available to patients in the Nordic Region and other European countries later in 2025. This expansion is in response to concerns about the contracting availability of I-131 products in Europe's nuclear medicine industry.
Company Info
Location
paris, ile de france, france
Additional Info
Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world.
We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation.